Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Paula C. Senger de Castro"'
Autor:
Thaisa Kowalski Furlan, Marcello Imbrizi, Daniela Magro, Paula C. Senger de Castro, Rodrigo Bremer Nones, Eron Fabio Miranda, Paulo G. Kotze
Publikováno v:
Journal of Coloproctology, Vol 44, Iss 03, Pp e187-e195 (2024)
Introduction and Objectives Certolizumab Pegol (CZP) is an anti-TNF agent approved in Brazil for Crohn's disease (CD). There is a lack of data in Brazil and Latin America detailing real-world experiences with CZP. The primary objective was clinical r
Externí odkaz:
https://doaj.org/article/824343b1774646e0be3b27e0774e6b7c
